Risk-based mammography screening
Risk-based mammography screening has been studied in 1 paper since 2026: none in people yet; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jan 2, 2026: “Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US”.
1 paper studies it2 findingsUpdated
See all 1 papers on risk-based mammography screening
- In silico1
What did studies of risk-based mammography screening find?
2Studies of risk-based mammography screening measured 2 outcomes: false-positive recalls and breast cancer mortality.
False-positive recalls
downin silico1
1 study
False-positive recalls
downin silico1
Risk-based mammography screening decreases false-positive recalls in silico (simulated US women born in 1980) (8% to 23% reduction).
“as well as reduced false-positive recalls by 8% to 23% (1050-1257 per 1000 women for risk-based screening strategies vs 1365 per 1000 women for B40-74)”
In silicosimulated US women born in 1980females
Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US
JAMA network open
Breast cancer mortality
downin silico1
1 study
Breast cancer mortality
downin silico1
Risk-based mammography screening decreases breast cancer mortality in silico (simulated US women born in 1980) (6.8-7.5 per 1000 women vs 6.8 per 1000 women).
“Nine risk-based screening strategies were associated with a comparable or greater number of deaths averted than biennial age-based screening from ages 40 to 74 years”
In silicosimulated US women born in 1980females
Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US
JAMA network open